Published: January 2018
Roots Analysis has announced the addition of 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035’ report to its list of offerings. The report provides a comprehensive analysis of the current landscape and future outlook of the growing market of 3D bioprinting within the healthcare domain.
Kavya Verma, the principal analyst, stated, “The current applications of 3D bioprinted products in the pharmaceutical industry cater to the various requirements for clinical testing of therapeutic drugs. Owing to the evident interspecies differences, drug candidates that are shown to be efficacious in animal models often fail in humans. To overcome such challenges, 3D bioprinting can be used to develop more accurate, human specific disease models. Clearly, the potential long-term application of 3D bioprinting is the production of synthetic and viable organs that can be transplanted in humans. This is anticipated to bridge the gap between the demand and supply of organs for transplantation purposes.”
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Amongst other things, the report features:
Verma further added, “The current market landscape of 3D bioprinting is characterized by the presence of nearly equal number of industry and non-industry players, featuring a number of start-ups and university spin-offs. The field has seen the emergence of several new players in the past few years; in fact, several well-known players of the 3D printing industry have broadened their focus to launch new initiatives specific to 3D bioprinting.Although several 3D bioprinting technologies are already available, active efforts are being made to add to the intellectual property portfolio. The field has witnessed growing partnering activity and has also managed to capture the interest of both public and private sector investors.”
The report highlights the contributions of several players in the field; some of the examples are listed below:
The opinions and insights discussed in this report were influenced by valuable inputs from senior stakeholders in the industry. The report features detailed transcripts of interviews held with Douglas Chrisey (Professor, Tulane University), Lisa Oliver (Doctor, University of Nantes) and Fanny Geraldo (Engineer, University of Nantes), Glauco R Souza (President and Chief Scientific Officer, n3D Biosciences), Igor Zlatkin (Application Scientist, Digilab), Kenneth Church (President and Chief Executive Officer, nScrypt) and Xudong Chen (Executive Vice President Business Development & Sales, nScrypt), Laura Bosworth (Chief Executive Officer and Co-founder, TeVido BioDevices), Lauralyn McDaniel (Industry Manager, SME), Marc Thurner (Chief Executive Officer, regenHU), Roger Narayan (Professor, North Carolina State University) and Simon Fried (Chief Business Officer, Nano Dimension).
For additional details, please visit
About Roots Analysis
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at firstname.lastname@example.org
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry